From: Antimicrobial activity and mechanism of action of Nu-3, a protonated modified nucleotide
 | MIC | |||
---|---|---|---|---|
Strains | Nu-3 (mg/ml) | Ciprofloxacin (μg/ml) | Oxacillin (μg/ml) | Vancomycin (μg/ml) |
Brucella abortus | >2.2 | 1 | - | - |
Burkholderia mallei | >4.4 | 1 | - | - |
Burkholderia pseudomallei | 4.4 | 1 | - | - |
Bacillus anthracis (Sterne) | 2.2 | 0.08 | - | - |
Francisella tularensis | 2.2 | 0.08 | - | - |
Yersinia pestis | 4.4 | 0.16 | - | - |
Staphylococcus aureus cvcc 2248 | 4.4 | 8 | - | - |
Pseudomonas aeruginosa cvcc 5668 | 8.8 | 4 | - | - |
MSSA ATCC 29213 | 8.8 | - | 0.4 | 1 |
MRSA ATCC 33591 | >4.4 | - | 256 | 2 |
S. aureus ATCC 700699 GISA | 8.8 | - | >32 | 32 |
Stanford University MRSA Clinical Isolate #1 | >4.4 | - | 256 | 2 |
Stanford University MRSA Clinical Isolate #2 | 8.8 | - | 128 | 1 |
Stanford University MRSA Clinical Isolate #3 | 8.8 | - | >256 | 4 |
Stanford University MRSA Clinical Isolate #4 | 8.8 | - | 32 | 1 |
Stanford University MRSA Clinical Isolate #5 | 8.8 | - | 32 | 1 |